The Prostate

Keyphrases

Publications

2023

Gerard Bray, Arya Bahadori, Darren Rama
Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic review. The Prostate (2023)
Santhosh Kumar Karthikeyan, Nuo Xu, James E Ferguson Rd, Soroush Rais-Bahrami, Zhaohui S Qin, Upender Manne, George J Netto, Darshan S Chandrashekar, Sooryanarayana Varambally
Identification of androgen response-related lncRNAs in prostate cancer. The Prostate (2023)
Andrew Stangl, Christopher Wilner, Pin Li, Lucas Maahs, Clara Hwang, Amanda Pilling
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer. The Prostate (2023)
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Alekandser Kosmala, Markus Essler, Thorsten Derlin, Takahiro Higuchi, Constantin Lapa, Andreas K Buck, Kenneth J Pienta, Martin A Lodge, Mario A Eisenberger, Mark C Markowski, Martin G Pomper, Michael A Gorin, Eric C Frey, Steven P Rowe, Ralph A Bundschuh
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort. The Prostate (2023)
Tenaw Yimer Tiruye, Michael O'Callaghan, Kerry Ettridge, Alex Jay, Kerry Santoro, Kim Moretti, Kerri Beckmann
Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate (2023)
Mark Nathaniel Adams, Laura V Croft, Aaron Urquhart, Mohamed Ashick Mohamed Saleem, Anja Rockstroh, Pascal H G Duijf, Patrick B Thomas, Genevieve P Ferguson, Idris Mohd Najib, Esha T Shah, Emma Bolderson, Shivashankar Nagaraj, Elizabeth D Williams, Colleen C Nelson, Kenneth J O'Byrne, Derek J Richard
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancer. The Prostate (2023)
Prasanna Ram, Swarnendu Mandal, Manoj K Das, Prasant Nayak
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate (2023)
Yusuph Mavura, Hanbing Song, Jamie Xie, Pablo Tamayo, Abdullahi Mohammed, Ahmad T Lawal, Ahmad Bello, Sani Ibrahim, Mohammed Faruk, Franklin W Huang
Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancer. The Prostate (2023)
Mosunmoluwa Oyenuga, Susan Halabi, Abayomi Oyenuga, Sean McSweeney, Alicia K Morgans, Charles J Ryan, Anna Prizment
Quality of life outcomes for patients with metastatic castration-resistant prostate cancer and pretreatment prognostic score. The Prostate (2023)
Nobushige Takeshita, Shinichi Sakamoto, Yasutaka Yamada, Tomokazu Sazuka, Yusuke Imamura, Akira Komiya, Koichiro Akakura, Nobuo Sato, Hiroomi Nakatsu, Takuma Kato, Mikio Sugimoto, Toyonori Tsuzuki, Tomohiko Ichikawa
Detection of intraductal carcinoma in prostate cancer patients with small tumor volume. The Prostate (2023)
Caitlin R Semsarian, Tara Ma, Brooke Nickel, Alexandra Barratt, Murali Varma, Brett Delahunt, Jeremy Millar, Lisa Parker, Paul Glasziou, Katy J L Bell
Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label. The Prostate (2023)
Bruno Rodrigues Lebani, André da Silva Barcelos, Denise Sbrissia E Silva Gouveia, Marcia Eli Girotti, Eduardo Pinto Remaille, Milton Skaff, Fernando Gonçalves Almeida
The role of transurethral resection of prostate (TURP) in patients with underactive bladder: 12 months follow-up in different grades of detrusor contractility. The Prostate (2023)
Mitchell M Conover, James Weaver, Bo Fan, Gerhard Leitz, Ute Richarz, Qing Li, Dina Gifkins
Cardiovascular outcomes among patients with castration-resistant prostate cancer: A comparative safety study using US administrative claims data. The Prostate (2023)
Qian Zhuang, Shengsong Huang, Zhenfei Li
Prospective role of 3βHSD1 in prostate cancer precision medicine. The Prostate (2023)
Sabina Davidsson, Anna Messing Eriksson, Ruzan Udumyan, Per Swanholm, Maria Lewin Lundh, Carolina Widing, Christina Lindlöf, Jonna Fridfeldt, Sven-Olof Andersson, Katja Fall
Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection. The Prostate (2023)
Romain Diamand, Alexandre Peltier, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Giuseppe Chiacchio, Valerio Beatrici, Riccardo Mastroianni, Giuseppe Simone, Olivier Windisch, Daniel Benamran, Alexandre Fourcade, Truong A Nguyen, Georges Fournier, Gaëlle Fiard, Guillaume Ploussard, Thierry Roumeguere, Simone Albisinni
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy. The Prostate (2023)
Pontus Röbeck, Lidi Xu, Dilruba Ahmed, Anca Dragomir, Pär Dahlman, Michael Häggman, Sam Ladjevardi
P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer. The Prostate (2023)
Tenaw Yimer Tiruye, Michael O'Callaghan, Kerry Ettridge, Alex Jay, Kerry Santoro, Kim Moretti, Kerri Beckmann
Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate (2023)

volume 83, number 5, 2023

Yusuph Mavura, Hanbing Song, Jamie Xie, Pablo Tamayo, Abdullahi Mohammed, Ahmad T Lawal, Ahmad Bello, Sani Ibrahim, Mohammed Faruk, Franklin W Huang
Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancer. The Prostate 83 (5) (2023)
Yusuph Mavura, Hanbing Song, Jamie Xie, Pablo Tamayo, Abdullahi Mohammed, Ahmad T Lawal, Ahmad Bello, Sani Ibrahim, Mohammed Faruk, Franklin W Huang
Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancer. The Prostate 83 (5) (2023)

volume 83, number 6, 2023

Santhosh Kumar Karthikeyan, Nuo Xu, James E Ferguson Rd, Soroush Rais-Bahrami, Zhaohui S Qin, Upender Manne, George J Netto, Darshan S Chandrashekar, Sooryanarayana Varambally
Identification of androgen response-related lncRNAs in prostate cancer. The Prostate 83 (6) (2023)
Tariq A Bhat, Arpit Dheeraj, Dhanya K Nambiar, Surya Pratap Singh, Dong Sool Yim, Rana P Singh
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. The Prostate 83 (6) (2023)
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Alekandser Kosmala, Markus Essler, Thorsten Derlin, Takahiro Higuchi, Constantin Lapa, Andreas K Buck, Kenneth J Pienta, Martin A Lodge, Mario A Eisenberger, Mark C Markowski, Martin G Pomper, Michael A Gorin, Eric C Frey, Steven P Rowe, Ralph A Bundschuh
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort. The Prostate 83 (6) (2023)
Romain Diamand, Alexandre Peltier, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Giuseppe Chiacchio, Valerio Beatrici, Riccardo Mastroianni, Giuseppe Simone, Olivier Windisch, Daniel Benamran, Alexandre Fourcade, Truong A Nguyen, Georges Fournier, Gaëlle Fiard, Guillaume Ploussard, Thierry Roumeguere, Simone Albisinni
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy. The Prostate 83 (6) (2023)
Romain Diamand, Alexandre Peltier, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Giuseppe Chiacchio, Valerio Beatrici, Riccardo Mastroianni, Giuseppe Simone, Olivier Windisch, Daniel Benamran, Alexandre Fourcade, Truong A Nguyen, Georges Fournier, Gaëlle Fiard, Guillaume Ploussard, Thierry Roumeguere, Simone Albisinni
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy. The Prostate 83 (6) (2023)
Caitlin R Semsarian, Tara Ma, Brooke Nickel, Alexandra Barratt, Murali Varma, Brett Delahunt, Jeremy Millar, Lisa Parker, Paul Glasziou, Katy J L Bell
Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label. The Prostate 83 (6) (2023)
Shahrokh F Shariat, Kenichi Hata, Shintaro Narita, Shingo Hatakeyama, Keiichiro Mori, Yuji Yata, Takayuki Sano, Takashi Otsuka, Shuhei Hara, Keiichiro Miyajima, Yuki Enei, Wataru Fukuokaya, Minoru Nakazono, Akihiro Matsukawa, Jun Miki, Tomonori Habuchi, Chikara Ohyama, Shahrokh F Shariat, Takahiro Kimura
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy. The Prostate 83 (6) (2023)
Nobushige Takeshita, Shinichi Sakamoto, Yasutaka Yamada, Tomokazu Sazuka, Yusuke Imamura, Akira Komiya, Koichiro Akakura, Nobuo Sato, Hiroomi Nakatsu, Takuma Kato, Mikio Sugimoto, Toyonori Tsuzuki, Tomohiko Ichikawa
Detection of intraductal carcinoma in prostate cancer patients with small tumor volume. The Prostate 83 (6) (2023)
Gerard Bray, Arya Bahadori, Darren Rama
Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic review. The Prostate 83 (6) (2023)
Caitlin R Semsarian, Tara Ma, Brooke Nickel, Alexandra Barratt, Murali Varma, Brett Delahunt, Jeremy Millar, Lisa Parker, Paul Glasziou, Katy J L Bell
Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label. The Prostate 83 (6) (2023)
Lih-Chyang Chen, Shu-Pin Huang, Chieh-Tien Shih, Chia-Yang Li, Yei-Tsung Chen, Chao-Yuan Huang, Chia-Cheng Yu, Victor C Lin, Cheng-Hsueh Lee, Jiun-Hung Geng, Bo-Ying Bao
ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysis. The Prostate 83 (6) (2023)
Rudolf A Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Alekandser Kosmala, Markus Essler, Thorsten Derlin, Takahiro Higuchi, Constantin Lapa, Andreas K Buck, Kenneth J Pienta, Martin A Lodge, Mario A Eisenberger, Mark C Markowski, Martin G Pomper, Michael A Gorin, Eric C Frey, Steven P Rowe, Ralph A Bundschuh
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort. The Prostate 83 (6) (2023)
Santhosh Kumar Karthikeyan, Nuo Xu, James E Ferguson Rd, Soroush Rais-Bahrami, Zhaohui S Qin, Upender Manne, George J Netto, Darshan S Chandrashekar, Sooryanarayana Varambally
Identification of androgen response-related lncRNAs in prostate cancer. The Prostate 83 (6) (2023)
Andrew Stangl, Christopher Wilner, Pin Li, Lucas Maahs, Clara Hwang, Amanda Pilling
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer. The Prostate 83 (6) (2023)
Sabina Davidsson, Anna Messing Eriksson, Ruzan Udumyan, Per Swanholm, Maria Lewin Lundh, Carolina Widing, Christina Lindlöf, Jonna Fridfeldt, Sven-Olof Andersson, Katja Fall
Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection. The Prostate 83 (6) (2023)
Prasanna Ram, Swarnendu Mandal, Manoj K Das, Prasant Nayak
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate 83 (6) (2023)
Gerard Bray, Arya Bahadori, Darren Rama
Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic review. The Prostate 83 (6) (2023)
Mohammed Shahait, Deborah Mukherji, Elai Davicioni, David I Lee
Commentary. The Prostate 83 (6) (2023)
Nobushige Takeshita, Shinichi Sakamoto, Yasutaka Yamada, Tomokazu Sazuka, Yusuke Imamura, Akira Komiya, Koichiro Akakura, Nobuo Sato, Hiroomi Nakatsu, Takuma Kato, Mikio Sugimoto, Toyonori Tsuzuki, Tomohiko Ichikawa
Detection of intraductal carcinoma in prostate cancer patients with small tumor volume. The Prostate 83 (6) (2023)
Prasanna Ram, Swarnendu Mandal, Manoj K Das, Prasant Nayak
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate 83 (6) (2023)
Lih-Chyang Chen, Shu-Pin Huang, Chieh-Tien Shih, Chia-Yang Li, Yei-Tsung Chen, Chao-Yuan Huang, Chia-Cheng Yu, Victor C Lin, Cheng-Hsueh Lee, Jiun-Hung Geng, Bo-Ying Bao
ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysis. The Prostate 83 (6) (2023)
Shahrokh F Shariat, Kenichi Hata, Shintaro Narita, Shingo Hatakeyama, Keiichiro Mori, Yuji Yata, Takayuki Sano, Takashi Otsuka, Shuhei Hara, Keiichiro Miyajima, Yuki Enei, Wataru Fukuokaya, Minoru Nakazono, Akihiro Matsukawa, Jun Miki, Tomonori Habuchi, Chikara Ohyama, Shahrokh F Shariat, Takahiro Kimura
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy. The Prostate 83 (6) (2023)
Jonathan A Aguiar, Eric V Li, Mohammad R Siddiqui, Moataz A Soliman, Sai K S R Kumar, Edward M Schaeffer, Mary Kate Keeter, C Hendricks Brown, Brittany M Szymaniak, Ashley E Ross
Utilization of genetic testing in men with advanced prostate cancer. The Prostate 83 (6) (2023)
Sabina Davidsson, Anna Messing Eriksson, Ruzan Udumyan, Per Swanholm, Maria Lewin Lundh, Carolina Widing, Christina Lindlöf, Jonna Fridfeldt, Sven-Olof Andersson, Katja Fall
Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection. The Prostate 83 (6) (2023)
Prasanna Ram, Prasant Nayak, Swarnendu Mandal, Manoj K Das, Sambit Tripathy
Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates. The Prostate 83 (6) (2023)
Prasanna Ram, Prasant Nayak, Swarnendu Mandal, Manoj K Das, Sambit Tripathy
Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates. The Prostate 83 (6) (2023)
Tariq A Bhat, Arpit Dheeraj, Dhanya K Nambiar, Surya Pratap Singh, Dong Sool Yim, Rana P Singh
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. The Prostate 83 (6) (2023)
Mohammed Shahait, Deborah Mukherji, Elai Davicioni, David I Lee
Commentary. The Prostate 83 (6) (2023)
Andrew Stangl, Christopher Wilner, Pin Li, Lucas Maahs, Clara Hwang, Amanda Pilling
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer. The Prostate 83 (6) (2023)
Jonathan A Aguiar, Eric V Li, Mohammad R Siddiqui, Moataz A Soliman, Sai K S R Kumar, Edward M Schaeffer, Mary Kate Keeter, C Hendricks Brown, Brittany M Szymaniak, Ashley E Ross
Utilization of genetic testing in men with advanced prostate cancer. The Prostate 83 (6) (2023)